Igor A. Sherman
Director Ejecutivo en Alpha Cancer Technologies, Inc. .
Cargos activos de Igor A. Sherman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Alpha Cancer Technologies, Inc. develops oncology and auto-immune disease treatments. Its products include Alpha Fetoprotein, immunotherapy and targeted chemotherapy platform. The company was founded by Igor A. Sherman in 2008 and is headquartered in Toronto, Canada. | Director Ejecutivo | 01/01/2008 | - |
Fundador | 01/01/2008 | - | |
Presidente | 01/01/2008 | - |
Historial de carrera de Igor A. Sherman
Antiguos cargos conocidos de Igor A. Sherman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Analista-Renta Fija | 01/01/2005 | 01/08/2010 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Director Técnico/Científico/I+D | - | - |
Formación de Igor A. Sherman.
University of Connecticut | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Reino Unido | 2 |
Canadá | 2 |
Operativa
Analyst-Fixed Income | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Alpha Cancer Technologies, Inc.
Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Alpha Cancer Technologies, Inc. develops oncology and auto-immune disease treatments. Its products include Alpha Fetoprotein, immunotherapy and targeted chemotherapy platform. The company was founded by Igor A. Sherman in 2008 and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Igor A. Sherman
- Experiencia